Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999;20(5-6):393-5.

Immunohistochemical expression of BerEP4, a new epithelial antigen, in endometrial carcinoma: correlation with clinical parameters

P L Cherchi  1 , L Bosincu, S Dessole, G A Ruiu, P Cossu Rocca, G Capobianco, F Tanda, A Ambrosini
Affiliations
  • PMID: 10609503

Immunohistochemical expression of BerEP4, a new epithelial antigen, in endometrial carcinoma: correlation with clinical parameters

P L Cherchi et al. Eur J Gynaecol Oncol. 1999.

Abstract

Objective: To assess the immunochemical expression of BerEP4, a new epithelial antigen in endometrial carcinoma.

Methods: We studied 45 cases of endometrial carcinoma in which the BerEP4, CEA and TAG-72 antigens were searched by an immunohistochemical method. We evaluated the correlations among the immunohistochemical positivity and the grading, histotype, stage and receptorial status of the neoplasia.

Results: CEA was positive in 29 out of 45 cases (64.4%), TAG-72 in 17 out of 45 cases (37.7%) and BerEP4 in 31 out of 45 cases (68.9%). Both TAG-72 and CEA were inversely related to the grading while, with regard to the histotype, CEA resulted as highly positive in the 5 cases of adenoacanthoma.

Conclusion: BerEP4 did not show any correlation with grading, histotype, stage of disease or receptorial status of the carcinoma.

PubMed Disclaimer